12 compounding sourcing platforms compared, as open data

Yes, open comparison data exists. As of 19 September 2026, Clinic Partner Guide'sCompounded Sourcing Platform IndexSource 1compares 12 compounded-medication sourcing platforms for licensed clinics on 7 weighted criteria, each score read from the platform's own public pages (scored 2026-08-31)Source 2. The full data is free to download asCSVSource 2andJSONSource 3under CC BY 4.0.

Two more platforms, OnlyScripts and Pharm503, are listed with the reason they were not scored rather than dropped.Source 2

Clinic Partner Guide publishes the index and has a commercial affiliation with its highest-scoring platform, Avanta Pharma Group (5.0 out of 5, scored 2026-08-31)Source 2. Read every number below with that in mind.

A low score describes disclosure, not service. The methodology:"A platform that discloses little scores lower on transparency, which is a statement about its disclosure and not about its service."Source 4

"Platform" covers unlike businesses.Of the 12 scored rows, 5 are multi-pharmacy marketplaces (AutoPilotRx, Fizy Health, VitaRelay, Ironsail Pharma / ImpetusOne, CLR RX), 4 are directories, 1 is a GPO or buying network (The Banyan Network), 1 is a quote engine (CompoundingFinder) and 1 is a direct supply partner (Avanta Pharma Group), scored 2026-08-31.Source 2A clinic comparing "platforms" is comparing different business models.

Half describe an ordering system.6 of 12 score 4 or 5 on ordering workflow (scored 2026-08-31): Avanta Pharma Group, AutoPilotRx and Fizy Health at 5; VitaRelay, Ironsail and CLR RX at 4.Source 2The other 6 offer discovery, quotes or buying terms. The directories record no ordering function, CompoundingFinder's reason says "so it is not a reorder workflow", and The Banyan Network's says "no portal is described".Source 2

5 of 12 publish nothing about price that could be scored(scored 2026-08-31). Three are ordering platforms whose entry is a call or a demo: VitaRelay ("No pricing is published; entry is book a call."), Ironsail ("No pricing is published; the product sits behind a demo.") and CLR RX ("No pricing is published; entry is a private demo request.").Source 2The other two are Find My Compounder and the APC / A4PC Pharmacy Locator. Seewhich platforms publish clinic pricingSource 5.

Publishing something about price is not publishing a price.Of the 7 platforms that publish something, 1 reason contains price figures: Avanta Pharma Group's, which records per-vial list prices and three volume tiers (up to 24, 25 plus, 100 plus), scored 2026-08-31.Source 2The Banyan Network's reason reads: "The rates themselves are not published."Source 2

6 of 12 publish a price list or termsa clinic can read before signing up (scored 2026-08-31): Avanta Pharma Group, Fizy Health, VitaRelay, CompoundingFinder, Find My Chemist and Find My Compounder.Source 3

Turnaround is the least-published fact.6 of 12 publish nothing about turnaround that could be scored, more than any other criterion (scored 2026-08-31). Of the 6 that were scored, 4 reasons state there is no commitment: Fizy Health ("No turnaround commitment."), VitaRelay ("without a turnaround commitment"), CLR RX ("without a published turnaround") and The Banyan Network ("No turnaround is published.").Source 2CompoundingFinder's "1 to 2 business days" is, in its reason's words, "a wait for quotes rather than fulfilment".Source 2Seewhich platforms publish a turnaround timeSource 6.

Unknowns cluster in three criteria.12 of 84 criterion cells are not stated: 6 in turnaround, 5 in pricing transparency and 1 in security posture (Ironsail: "Nothing published on the public site."), scored 2026-08-31.Source 3Ordering workflow, direct accountability and onboarding speed have no unknowns.Source 3

No marketplace, network, directory or quote engine in the index is recorded as naming an account owner (scored 2026-08-31).Source 2The reasons for AutoPilotRx, Fizy Health and The Banyan Network record no named account owner; CLR RX's says "accountability sits with the platform rather than a named contact"; CompoundingFinder's says "The service ends at introduction".Source 2

Two ordering platforms put a demo in the entry path,2 of the 6 (scored 2026-08-31): Ironsail ("Entry is sign up or book a demo. A demo gate delays a first order.") and CLR RX ("Entry is a private demo request.").Source 2VitaRelay offers self-serve registration "alongside book a call".Source 2State coverage is compared separately on themulti-state coverage pageSource 7.

The index uses 7 criteria, weighted according to ourpublished methodologySource 4(v1.0, updated August 2026). Ordering workflow, pricing transparency and direct accountability carry 20% each. Multi-state coverage, turnaround, security posture and onboarding speed carry 10% each.Source 3

Silence is excluded rather than scored low: "A criterion neither published nor confirmed to us is recorded as unknown and excluded from the weighted average rather than scored low, so silence is not punished."Source 4The methodology adds: "That does mean two overall scores can rest on different numbers of criteria."Source 4

That shows in the data. Criteria evidenced runs from 60% to 100%, with a mean of 85.8% computed from the JSON (scored 2026-08-31).Source 3Ironsail Pharma / ImpetusOne ranks 5th at 3.33 on 60% of criteria weight evidenced, above CLR RX (3.25, 80%) and The Banyan Network (3.10, 100%).Source 3

Under the methodology, a criterion can be scored from what a platform publishes or from what it confirms to Clinic Partner Guide.Source 4In this version, all 84 criterion cells cite a published page, so anyone can check every score against the platform's own site (scored 2026-08-31).Source 3

Consumer GLP-1 price indexes record what patients pay telehealth programs. This index records what compounded-medication sourcing platforms publish to licensed clinics: ordering, pricing, accountability, states, turnaround, security and onboarding.Source 1It makes no clinical assessment.

Pharmacy directories list pharmacies. Here, 4 directories are themselves rows, scored on the same criteria: the Peptide Association Pharmacy Directory, Find My Chemist, Find My Compounder and the APC / A4PC Pharmacy Locator (scored 2026-08-31).Source 2A search on 19 September 2026 found no other open dataset on clinic sourcing platforms.

Regulatory context for clinics reading supplier data next to GLP-1 pricing: FDA's shortage listings for tirzepatide (December 2024) and semaglutide (February 2025) have ended, and FDA has since acted against marketing of compounded GLP-1s; what a 503A pharmacy may compound is patient-specific and varies by state. Source: fda.gov, "FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize", read 2026-09-19.Source 11

The index does not assess clinical quality, formulations or outcomes. It compares sourcing platforms, not 503A pharmacies themselves. For the choice between the two models, seebuying direct from a 503A pharmacy vs a sourcing partnerSource 8.

Two platforms are listed but not scored. OnlyScripts "Returned HTTP 503 on every attempt on 2026-08-29, so none of its claims could be read from its own pages." Pharm503 "States Join Waitlist and now accepting early access signups, so it is pre-launch."Source 2

The scores are a snapshot. In the methodology's words: "Scores are a snapshot of published information on the date shown."Source 4Supplier pages can change after 31 August 2026, so check the platform's own page on the day you decide.

The license isCC BY 4.0Source 10. The attribution string set in the CSV header and the JSON is "Compounded Sourcing Platform Index, clinicpartnerguide.com".Source 2A citation that carries the date: Compounded Sourcing Platform Index, clinicpartnerguide.com, scored 2026-08-31, CC BY 4.0.

The file URLs arehttps://clinicpartnerguide.com/sourcing-platform-index.csvSource 2andhttps://clinicpartnerguide.com/sourcing-platform-index.jsonSource 3. The CSV downloads as sourcing-platform-index-2026-08-31.csv, so a saved copy keeps its scoring date.